B6.FVB-Tg(S100A8-BCL2)1Lgs/Orl
Status | Available to order |
EMMA ID | EM:14664 |
Citation information | RRID:IMSR_EM:14664 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | B6.FVB-Tg(S100A8-BCL2)1Lgs/Orl |
Alternative name | FVB/NMRP8hBCL-2 B6 |
Strain type | Transgenic Strains |
Allele/Transgene symbol | Tg(S100A8-BCL2)1Lgs |
Gene/Transgene symbol | Tg(S100A8-BCL2)1Lgs |
Information from provider
Provider | Irv Weissman |
Provider affiliation | Ludwig Centre for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine |
Genetic information | Human BCL-2 driven by the myeloid MRP8 promoter |
Phenotypic information | Homozygous:Not bred to homozygosity and maintained as hemizygousHeterozygous:Increased bone marrow blast cells |
Breeding history | Initial strain EM:12211 on FVB/N background was backcrossed 8 times on C57BL/6 |
References |
|
Homozygous fertile | not known |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6J males |
Literature references
- Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice.;Lagasse E, Weissman I L, ;1997;Cell;89;1021-31; 9215625
- Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia.;Traver D, Akashi K, Weissman I L, Lagasse E, ;1998;Immunity;9;47-57; 9697835
- BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.;Kogan S C, Brown D E, Shultz D B, Truong B T, Lallemand-Breitenbach V, Guillemin M C, Lagasse E, Weissman I L, Bishop J M, ;2001;The Journal of experimental medicine;193;531-43; 11181704
- Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.;Jaiswal Siddhartha, Traver David, Miyamoto Toshihiro, Akashi Koichi, Lagasse Eric, Weissman Irving L, ;2003;Proceedings of the National Academy of Sciences of the United States of America;100;10002-7; 12890867
- Over-expression of Bcl-2 provides protection in septic mice by a trans effect.;Iwata Akiko, Stevenson Vicki Morgan, Minard Annie, Tasch Michael, Tupper Joan, Lagasse Eric, Weissman Irving, Harlan John M, Winn Robert K, ;2003;Journal of immunology (Baltimore, Md. : 1950);171;3136-41; 12960340
- BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.;Omidvar Nader, Kogan Scott, Beurlet Stephanie, le Pogam Carole, Janin Anne, West Robert, Noguera Maria-Elena, Reboul Murielle, Soulie Annie, Leboeuf Christophe, Setterblad Niclas, Felsher Dean, Lagasse Eric, Mohamedali Azim, Thomas N Shaun B, Fenaux Pierre, Fontenay Michaela, Pla Marika, Mufti Ghulam J, Weissman Irving, Chomienne Christine, Padua Rose Ann, ;2007;Cancer research;67;11657-67; 18089795
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).